| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc4683025c350d57f6054df30b1e1ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59dd4abad9d7346c1a922663f1ab4db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1e6758955acb7d710ab0c2eb3ed70db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5747f58b3203c5e6c5fb2f407ecb9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e70d8d9f6fbd5b2ca637310a818b6c3 |
| publicationDate |
2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2016002023-A1 |
| titleOfInvention |
"Compounds derived from benzoate-4- (amidoamino) - substituted with an oxazole dicarboxylic group, enteropeptidase inhibitors; pharmaceutical composition comprising them; and its use in the treatment of obesity and diabetes mellitus ”. pct |
| abstract |
THE APPLICATION REFERS TO COMPOUNDS DERIVED FROM BENZOATO-4- (AMIDOAMINO) - REPLACED WITH AN OXAZOL DICARBOXYLL GROUP, ENTEROPEPTIDASE INHIBITORS, TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEMSELVES AND TO BE USED IN THE PROCESSING OF OBESITY AND OBESITY. |
| priorityDate |
2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |